Atypical antipsychotic drugs are often used to treat the behavioral and psychological symptoms of dementia (BPSD) even though they are not FDA-approved for this indication and concerns exist about their safety and lack of efficacy. To further discourage their use, in February 2015 CMS added the use of antipsychotics in calculation of the Nursing Home Compare star ratings. Prescribing of antipsychotics for short and long stay patients who do not have a diagnosis of schizophrenia, Huntington Chorea and Tourette’s Syndrome will reduce the nursing home’s quality score. This presentation describes the new star quality measure and identifies discontinuation strategies for antipsychotics and alternative approaches to managing BPSD and delirium in nursing homes.
- Discuss the FDA warnings on antipsychotic use in elderly with dementia and the associated risks
- Describe the CMS Five-Star Quality Rating System for nursing homes and the new antipsychotic use measure
- Identify alternatives to using antipsychotics in patients with dementia